Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes . Clinics [Internet]. 2011 Jan. 1 [cited 2024 May 9];66(5):793-9. Available from: https://www.revistas.usp.br/clinics/article/view/19555